Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

INTRODUCTION: Abnormalities in lipid metabolism may contribute to the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Fenofibrate induces early and reversible reduction in estimated glomerular filtration rate (eGFR), but it may have protective effects on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Frazier, Rebecca, Mehta, Rupal, Cai, Xuan, Lee, Jungwha, Napoli, Sara, Craven, Timothy, Tuazon, Jennifer, Safdi, Adam, Scialla, Julia, Susztak, Katalin, Isakova, Tamara
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308372/
https://ncbi.nlm.nih.gov/pubmed/30596172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.09.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados